CRYSTALS OF ALKYNYL-CONTAINING COMPOUND, SALT AND SOLVATE THEREOF, METHOD OF PRODUCTION AND WAYS OF APPLICATION THEREOF Russian patent published in 2024 - IPC C07D471/04 A61K31/496 A61P35/00 A61P35/02 

Abstract RU 2829609 C1

FIELD: chemistry.

SUBSTANCE: invention relates to a method of producing crystalline form I 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide, characterized by characteristic peaks at the following positions on the XRPD diagram, expressed in values of angle 2θ: 9.498 ± 0.2°, 12.293 ± 0.2°, 13.045 ± 0.2°, 15.899 ± 0.2°, 16.199 ± 0.2°, 18.183 ± 0.2°, 18.327 ± 0.2°, 21.755 ± 0.2°, 22.362 ± 0.2°, 25.690 ± 0.2°, or characteristic peaks at 8.968± 0.2°, 9.498 ± 0.2°, 12.293 ± 0.2°, 13.045 ± 0.2°, 15.899 ± 0.2°, 16.199 ± 0.2°, 16.533 ± 0.2°, 16.908 ± 0.2°, 18.183 ± 0.2°, 18.327 ± 0.2°, 20.042 ± 0.2°, 20.271 ± 0.2°, 21.755 ± 0.2°, 22.362 ± 0.2°, 25.690 ± 0.2°. Method involves crystallisation 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide in an organic solvent, wherein the crystallisation method is stirring at room temperature or adding an anti-solvent; crystallization temperature is 20–50 °C. If crystallisation is carried out by means of a stirring method at room temperature, the organic solvent is heptane, methanol, ethanol, isopropanol, methyl-tert-butyl ether, acetonitrile, acetone, 2-butanone, ethyl acetate and isopropyl acetate; if an anti-solvent is used for crystallisation, the organic solvent is DMSO; anti-solvent is water, isopropanol and acetonitrile.

EFFECT: obtaining crystalline form I 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide, having good stability, with high reproducibility.

5 cl, 59 dwg, 24 tbl, 30 ex

Similar patents RU2829609C1

Title Year Author Number
AZABICYCLIC COMPOUND CRYSTALS 2016
  • Uno, Takao
RU2697521C2
CRYSTALLINE FORMS OF THE TLR7/TLR8 INHIBITOR 2019
  • Bieri, Nicole
  • Kordikowski, Andreas
  • Li, Bin
  • Lustenberger, Philipp
  • Ramos, Rita
  • Sethuraman, Vijay
  • Zhang, Sisi
RU2792005C2
CRYSTALS OF 3,5-DISUBSTITUTED BENZOLALKYNYL COMPOUND 2016
  • Egami Kosuke
RU2672563C1
COMPOUNDS AND METHODS FOR INHIBITING JAK 2016
  • Astrand Annika Birgitta Margareta
  • Grimster Neil Patrick
  • Kawatkar Sameer
  • Kettle Jason Grant
  • Nilsson Magnus K.
  • Ruston Linette Lys
  • Su Qibin
  • Vasbinder Melissa Marie
  • Winter-Holt Jon James
  • Wu Dedong
  • Yang Wenzhan
  • Grecu Tudor
  • Mccabe James
  • Woessner Richard Donald
  • Chuaqui Claudio Edmundo
RU2760359C2
POLYMORPHIC MODIFICATIONS OF N-[(3-FLUORO-4-METHOXYPYRIDINE-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({ 4-[(2-OXOPYRIDINE-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AND THEIR SALTS 2017
  • Beaton, Haydn
  • Crowe, David Malcolm
  • Edwards, Hannah Joy
  • Griffiths-Haynes, Nicholas James
RU2756273C2
SALT OF MU-OPIOID RECEPTOR (MOR) AGONIST, CRYSTAL FORM I OF ITS FUMARATE SALT, AND THEIR PRODUCTION METHOD 2018
  • Wang, Lin
  • Wang, Likun
RU2779119C2
6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINONE DERIVATIVE AND ITS APPLICATION IN MEDICINE 2018
  • Ikuma, Yohei
  • Tojo, Kengo
  • Fukazawa, Ryo
  • Masumoto, Shuji
RU2792694C2
MULTIKINASE INHIBITOR COMPOUND AND ITS CRYSTALLINE FORM AND USE 2017
  • Wu Frank
RU2723985C1
CRYSTALLINE OR AMORPHOUS FORM OF FXR AGONISTS BEING STEROID DERIVATIVES, THEIR PRODUCTION METHOD AND THEIR USE 2018
  • Li, Syaolin
  • Syao, Khualin
  • Li, Pen
  • Khe, Khajin
  • Li, Vejdun
RU2800751C2
PRODRUGS OF PYRIDONAMIDES USED AS MODULATORS OF SODIUM CHANNELS 2014
  • Anderson Kori
  • Adida-Rua Sara Sabina
  • Golek Dzhulian Merian Charlz
  • Chzhan Bejli
  • Littler Bendzhamin Dzhozef
  • Keskhavarz-Skhokri Ali
  • Alkasio Tim Edvard
  • Belmont Deniel T.
RU2692766C1

RU 2 829 609 C1

Authors

Wen, Jianfeng

Lin, Yanqiong

Feng, Jianpeng

Wu, Tianzhu

Shao, Zhenzhong

Li, Weidong

Dates

2024-11-01Published

2021-07-01Filed